{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:10:13Z","timestamp":1787454613211,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Insulin resistance (IR) with associated compensatory hyperinsulinemia (HI) are early abnormalities in the etiology of prediabetes (preT2D) and type 2 diabetes (T2D). IR and HI also associate with increased erythrocytosis. Hemoglobin A1c (HbA1c) is commonly used to diagnose and monitor preT2D and T2D, but can be influenced by erythrocytosis independent of glycemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We undertook bidirectional Mendelian randomization (MR) in individuals of European ancestry to investigate potential causal associations between increased fasting insulin adjusted for BMI (FI), erythrocytosis and its non-glycemic impact on HbA1c. We investigated the association between the triglyceride-glucose index (TGI), a surrogate measure of IR and HI, and glycation gap (difference between measured HbA1c and predicted HbA1c derived from linear regression of fasting glucose) in people with normoglycemia and preT2D.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Inverse variance weighted MR (IVWMR) suggested that increased FI increases hemoglobin (Hb, b=0.54 \u00b1 0.09, p=2.7 x 10<jats:sup>-10<\/jats:sup>), red cell count (RCC, b=0.54 \u00b1 0.12, p=5.38x10<jats:sup>-6<\/jats:sup>) and reticulocyte (RETIC, b=0.70 \u00b1 0.15, p=2.18x10<jats:sup>-6<\/jats:sup>). Multivariable MR indicated that increased FI did not impact HbA1c (b=0.23 \u00b1 0.16, p=0.162) but reduced HbA1c after adjustment for T2D (b=0.31 \u00b1 0.13, p=0.016). Increased Hb (b=0.03 \u00b1 0.01, p=0.02), RCC (b=0.02 \u00b1 0.01, p=0.04) and RETIC (b=0.03 \u00b1 0.01, p=0.002) might modestly increase FI. In the observational cohort, increased TGI associated with decreased glycation gap, (i.e., measured HbA1c was lower than expected based on fasting glucose, (b=-0.09 \u00b1 0.009, p&amp;lt;0.0001)) in people with preT2D but not in those with normoglycemia (b=0.02 \u00b1 0.007, p&amp;lt;0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MR suggests increased FI increases erythrocytosis and might potentially decrease HbA1c by non-glycemic effects. Increased TGI, a surrogate measure of increased FI, associates with lower-than-expected HbA1c in people with preT2D. These findings merit confirmatory studies to evaluate their clinical significance.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1146099","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:44:21Z","timestamp":1679031861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Investigating the association between fasting insulin, erythrocytosis and HbA1c through Mendelian randomization and observational analyses"],"prefix":"10.3389","volume":"14","author":[{"given":"Anthony","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Khafagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba","family":"Hashemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin H. M.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delnaz","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0035","article-title":"Hemoglobin a 1c-using epidemiology to guide medical practice: Kelly West award lecture 2020","volume":"44","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"B2","unstructured":"Global report on diabetes2016"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: An analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: A pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37432","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1057","article-title":"Late relapse of diabetes after bariatric surgery: Not rare, but not a failure","volume":"43","author":"Aminian","year":"2020","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30068-3","article-title":"Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial","volume":"7","author":"Lean","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications: the DPP outcomes study","volume":"3","author":"Nathan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjd.2017.10.007","article-title":"Monitoring Glycemic Control","volume-title":"Can J Diabetes","author":"Berard","year":"2018"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0034","article-title":"Consensus report: Definition and interpretation of remission in type 2 diabetes","volume":"44","author":"Riddle","year":"2021","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S319895","article-title":"A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives","author":"Reed","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21035","article-title":"Association of sickle cell trait with hemoglobin A1c in African americans","volume":"317","author":"Lacy","year":"2017","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4121","article-title":"Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes","volume":"100","author":"Fizelova","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12010","article-title":"Determinants of HbA1c in nondiabetic Dutch adults: Genetic loci and clinical and lifestyle parameters, and their interactions in the lifelines cohort study","volume":"273","author":"Jansen","year":"2013","journal-title":"J Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101590","article-title":"The association between hematological parameters and insulin resistance is modified by body mass index \u2013 results from the north-East Italy MoMa population study","volume":"9","author":"Barazzoni","year":"2014","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0566","article-title":"Beyond erythropoiesis: Emerging metabolic roles of erythropoietin","volume":"63","author":"Woo","year":"2014","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100634","article-title":"New aspects of the insulin resistance syndrome: Impact on haematological parameters","volume":"44","author":"Barbieri","year":"2001","journal-title":"Diabetologia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400927","article-title":"The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. studies in vitro under serum-free conditions\u2013comparison to other cytokines and growth factors","volume":"12","author":"Ratajczak","year":"1998","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408.001","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","article-title":"The polygenic and monogenic basis of blood traits and diseases","volume":"182","author":"Vuckovic","year":"2020","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","article-title":"Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00870-7","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes","volume":"9","author":"Xue","year":"2018","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-Scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry","volume":"28","author":"Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/figshare.21913053","article-title":"Association between obesity and chronic kidney disease: multivariable mendelian randomization analysis and observational data from a bariatric surgery cohort","author":"Nguyen","year":"2023","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable mendelian randomization","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.28.21259622v1","article-title":"Navigating sample overlap, winner\u2019s curse and weak instrument bias in mendelian randomization studies using the UK biobank","author":"Sadreev","year":"2021","journal-title":"medRxiv"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable mendelian randomization in the single-sample and two-sample summary data settings","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? insights from a mediation analysis of the EMPA-REG OUTCOME trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2307\/2965703","article-title":"Improvements on cross-validation: The .632+ bootstrap method","volume":"92","author":"Efron","year":"1997","journal-title":"J Am Stat Assoc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-europe): A cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.08.010","article-title":"Impact of rare and common genetic variants on diabetes diagnosis by hemoglobin A1c in multi-ancestry cohorts: The trans-omics for precision medicine program","volume":"105","author":"Sarnowski","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa658","article-title":"Genome-wide association for HbA1c in Malay identified deletion on SLC4A1 that influences HbA1c independent of glycemia","volume":"105","author":"Chai","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","article-title":"Association between hemoglobin A1c and glycemia in African americans with and without sickle cell trait and whites, results from CARDIA and the Jackson heart study","volume":"3","author":"Wu","year":"2018","journal-title":"J Diabetes Treat"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002384","article-title":"HbA1c for type 2 diabetes diagnosis in africans and African americans: Personalized medicine NOW","volume":"14","author":"Paterson","year":"2017","journal-title":"PloS Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19366-9","article-title":"Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability","volume":"12","author":"Lagou","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1146099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:44:29Z","timestamp":1679031869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1146099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":44,"alternative-id":["10.3389\/fendo.2023.1146099"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1146099","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1146099"}}